Our Gene Synthesis Service supports biotechnology companies, pharmaceutical research teams, synthetic biology groups, CROs, and academic laboratories that need accurate DNA constructs built directly from digital sequence information. Custom gene synthesis is widely used when a project requires de novo coding sequences, codon-optimized expression constructs, engineered variants, reporter cassettes, cloning-ready inserts, or template DNA for downstream workflows. For many teams, the main value is not only obtaining a gene sequence, but reducing delays caused by template sourcing, multi-step cloning, sequence instability, and repeated redesign cycles.
We combine sequence review, codon and motif optimization, construct architecture planning, gene assembly, cloning, analytical verification, and project-oriented documentation to help clients move efficiently from design concept to usable DNA material. By aligning synthesis strategy with host system, vector requirements, sequence complexity, and downstream experimental goals, we help research teams make better technical decisions earlier and receive gene products that are easier to deploy in expression, screening, assay development, and platform engineering programs.
No Reliable Starting Template: Many projects begin with a protein sequence, a published accession, or a redesigned construct rather than existing physical DNA. Gene synthesis removes dependence on template acquisition, reverse transcription, strain sourcing, and iterative subcloning, making it easier to start directly from the required sequence.
Expression Bottlenecks: Native genes are often poorly matched to the intended host or expression strategy. We support codon optimization, unwanted motif removal, GC balancing, and sequence redesign to improve construct usability while preserving the intended protein sequence and project logic.
Difficult DNA Features: High-GC segments, repeats, homopolymers, secondary structure, and unstable motifs can delay ordinary cloning workflows or reduce synthesis success. Our design and build planning helps identify these risks early and select a more practical route for complex sequence delivery.
Vector and Construct Complexity: Projects frequently require tags, linkers, enzyme sites, promoters, untranslated regions, fusion domains, or custom vector onboarding. We help organize these elements into a synthesis-ready design so teams can avoid avoidable rework during construct assembly and downstream testing.
Verification and Handoff Risk: A gene project is only useful when sequence identity, cloning context, and delivery format are clear. Our workflow combines sequence confirmation, construct review, and structured reporting, and can be coordinated with broader DNA synthesis and Sensitive DNA/RNA Synthesis Platform capabilities when projects require more specialized design support.
Our gene synthesis services are designed for teams that need more than a simple DNA build. We support construct planning, sequence optimization, cloning strategy selection, difficult-sequence assessment, variant generation, and delivery of research-ready DNA materials aligned with downstream experimental use.
Whether the goal is protein expression, pathway engineering, CRISPR research, assay development, or IVT template preparation, we provide coordinated technical support from intake through sequence-verified delivery so clients can reduce internal cloning workload and accelerate project progression.
The table below helps research teams match project intent with an appropriate gene synthesis service format, expected design inputs, and practical output package.
| Service Format | Best Suited For | Key Design Inputs | Typical Deliverables | Why Teams Choose It |
| Standard Gene Build | Routine de novo coding sequences and cloning-ready inserts | Target sequence, vector preference, cloning sites, required tags | Synthesized gene with agreed cloning format and sequence confirmation package | Replaces template-dependent cloning with a cleaner sequence-to-construct workflow |
| Codon-Optimized Gene | Expression programs that need host-matched DNA design | Protein sequence or coding region, host system, motif constraints, expression goals | Optimized gene design, final construct sequence, supporting change summary | Improves construct usability when native coding sequences are suboptimal for the planned host |
| Custom Vector Clone | Teams that need a synthesized gene directly in a preferred plasmid backbone | Insert sequence, vector map, junction rules, orientation requirements | Cloned construct, vector-context sequence files, project-specific documentation | Reduces internal cloning work and shortens the path to downstream testing |
| Variant Set | Mutational analysis, comparative screening, and construct panel development | Parent construct, mutation list, panel logic, naming scheme | Organized set of related constructs with sequence-level traceability | Makes it easier to evaluate multiple design hypotheses within one coordinated project |
| Long or Complex Construct | Sequences with repeats, high GC, multiple functional elements, or challenging architecture | Full construct design, high-risk regions, acceptable redesign boundaries, vector plan | Build strategy aligned with sequence risk and downstream use requirements | Helps rescue programs that are difficult to complete through routine assembly methods |
| DNA Template Construct | IVT template preparation and other downstream DNA-to-RNA workflows | Coding sequence, flanking features, transcription design requirements, linearization considerations | Research-use DNA construct prepared for downstream template handling | Creates a cleaner starting point for RNA-focused development and analytical work |
Project success in gene synthesis depends heavily on how early sequence complexity, vector constraints, and downstream use conditions are addressed. This matrix highlights the main technical factors that shape build strategy and service selection.
| Planning Factor | Why It Matters | What We Review | Where It Affects the Project | Service Response |
| GC Distribution | Local or global GC imbalance can complicate synthesis, assembly, and sequence verification | Overall GC pattern, local hotspots, codon flexibility, redesign tolerance | Design stage, assembly stage, analytical confirmation | Sequence redesign or codon tuning to improve manufacturability without changing intended protein output |
| Repeats and Homopolymers | Repetitive DNA can reduce assembly efficiency and increase cloning instability | Repeat length, repeat spacing, homopolymer burden, allowable sequence edits | Build feasibility, vector stability, QC interpretation | Early risk flagging and selection of a more appropriate synthesis strategy |
| Secondary Structure Risk | Hairpins and other sequence-driven structures can interfere with oligo performance and construct assembly | Local structure propensity, junction regions, cloning interfaces, redesign windows | Assembly planning and construct finalization | Sequence engineering to reduce problematic structural regions where feasible |
| Vector Compatibility | Insert success depends on backbone choice, cloning strategy, and junction design | Restriction sites, reading frame, promoter context, replication and selection features | Cloning, plasmid preparation, downstream expression or assay use | Construct architecture review before synthesis to reduce avoidable rework |
| Functional Elements | Tags, linkers, localization motifs, untranslated regions, and fusion domains affect construct behavior | Element order, spacer logic, junction integrity, sequence burden, intended readout | Design and post-delivery usability | Application-aware construct planning rather than sequence-only execution |
| Downstream Workflow | A construct designed for protein expression is not necessarily ideal for screening, IVT, or assay control use | Planned application, scale expectations, delivery format, documentation needs | Service selection, cloning format, final handoff | Output package matched to actual project use instead of a one-format-fits-all model |
| Variant Throughput | Multi-construct projects require naming discipline, panel logic, and sequence-level traceability | Mutation map, construct grouping, shared backbone logic, comparative design goals | Variant build planning and reporting | Coordinated panel synthesis to simplify downstream screening and data comparison |
| Material Requirements | Teams differ in whether they need cloning-ready DNA, confirmed plasmid, or expanded follow-on material | Amount, format, storage preference, handoff to adjacent services | Delivery planning and project completion | Project configuration that aligns the gene build with practical laboratory use |
Our workflow is built to help clients move from sequence concept to research-ready DNA with fewer redesign cycles, clearer technical checkpoints, and better alignment between construct design and downstream use.
We review the target sequence, intended host or assay context, vector preferences, required functional elements, and expected output format. This step ensures that the project is defined around real experimental needs rather than sequence submission alone.
The construct is assessed for codon usage, GC balance, repeats, secondary-structure risk, cloning-site logic, and sequence complexity. Where needed, we propose optimization paths that improve build feasibility while preserving the biological purpose of the construct.
We finalize the gene design, vector plan, junction regions, tags, linkers, and any required variant set logic. This planning stage is critical for avoiding downstream delays caused by frame errors, incompatible sites, or incomplete construct definitions.
The agreed DNA sequence is synthesized and assembled using a strategy suited to construct length and complexity. For higher-risk designs, build planning focuses on reducing instability and maintaining sequence integrity through the manufacturing process.
Where cloning is part of scope, the synthesized gene is placed into the selected vector and checked against the agreed construct plan. Sequence confirmation and project-specific quality review provide the analytical confidence needed before downstream experimental use.
Final materials and documentation are delivered in the agreed format, with sequence files and construct information prepared for internal R&D, external collaborators, or follow-on workflow transfer. Post-delivery support helps teams move efficiently into expression, screening, or template-based applications.
We position gene synthesis as a project-solving service rather than a simple DNA ordering function. Our support model is designed to help clients reduce technical ambiguity, improve construct usability, and connect sequence design with real downstream research requirements.
Synthetic genes are used across modern molecular biology and platform development whenever researchers need precise DNA constructs without the uncertainty of template-dependent cloning. Our service supports a wide range of nonclinical research applications.
If your team needs a custom gene, codon-optimized construct, variant panel, cloning-ready insert, or sequence-defined DNA template, our Gene Synthesis Service can help you move from digital design to research-ready material with clearer planning and fewer avoidable delays. We support pharmaceutical research groups, biotech developers, CRO teams, and academic laboratories with project-oriented design review, complex-sequence assessment, construct assembly, cloning support, and documentation suited to real R&D workflows. Contact us to discuss your target sequence, vector requirements, and downstream goals.
Multiple synthesis approaches including optimized PCR assembly and chip-based methods effectively handle challenging sequences through specialized enzymatic systems and temperature-controlled processes.
All synthesized genes undergo comprehensive sequencing verification and quality control checks, with sequencing reports provided to confirm 100% sequence accuracy before delivery.
High-throughput synthesis platforms enable parallel processing of hundreds to thousands of genes, significantly reducing per-gene costs while maintaining individual sequence quality and accuracy.
Large genes are synthesized using modular assembly methods, with quality control checkpoints at each stage to ensure correct assembly of full-length sequences with verified functionality.
Loading ......
